Supplementary Figure 3 from Efficacy of ATR Kinase Inhibitor Elimusertib Monotherapy or Combination in Tumors with DNA Damage Response Pathway and Other Genomic Alterations
<p>Supplementary Figure 3. Change in body weight of mice bearing 10 different patient derived xenografts treated with elimusertib 40 mg/kg.</p>
Authors
- Yasmeen Q. Rizvi (ORCID: https://orcid.org/0009-0000-2719-4093)
- Kurt W. Evans (ORCID: https://orcid.org/0009-0008-6823-6809)
- Timothy P. DiPeri (ORCID: https://orcid.org/0000-0003-1190-1640)
- Argun Akçakanat (ORCID: https://orcid.org/0000-0002-4012-9840)
- Antje M. Wengner (ORCID: https://orcid.org/0009-0009-5772-1945)
- Timothy Anthony Yap (ORCID: https://orcid.org/0000-0002-2154-3309)
- Maria Gabriela Raso (ORCID: https://orcid.org/0000-0003-2105-5556)
- Funda Meric‐Bernstam (ORCID: https://orcid.org/0000-0001-6816-6072)
- Dhruv Chachad (ORCID: https://orcid.org/0000-0003-3131-7679)
- Kaushik Varadarajan (ORCID: https://orcid.org/0000-0002-4114-5498)
- Christian X. Cruz Pico (ORCID: https://orcid.org/0000-0002-5620-7727)
- Stephen M. Scott
Publication Details
- Published
- 2025-09-02
- DOI
- https://doi.org/10.1158/1535-7163.30028669
- Primary Topic
- Cancer Mechanisms and Therapy
- Type
- article
- Field-Weighted Citation Impact
- 0.00